keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One, September 12, 2024 - MT (Mexican Pacific Time, GMT-07:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day One, September 12, 2024 - MT (Mexican Pacific Time, GMT-07:00)
search
Streams
Formats
7:30am - 8:30am
Opening of Conference Registration, Continental Breakfast and Networking
Showing 1 of 1 Streams
General Session
8:30am - 8:45am
Informa Connect and Chair Welcome Remarks
- Missie Scheffman - National Reimbursement Director, Astellas
- Callie Mertel - Senior Conference Producer, Informa Connect
8:45am - 9:30am
Empowering Your Hub Program – Harnessing Cutting-Edge Technology for Ongoing Advancement
As the technology available for hub programs continues to rapidly evolve, take a look at
specific case studies on the tools and innovations that can be used to ease provider workflow and optimize patient outcome.
- Understand the role that disease state, as well as patient population and location, has on technology selection or the lack thereof
- Learn the importance of your technology being able to pivot throughout the hub lifecycle
9:30am - 10:15am
Executive Hub Insights – A Roundtable Discussion
Kickstart the Congress with a panel discussion comprised of top industry executives working with the hub space. Engage in a comparison of experiences, best practices and benchmarking across companies of varying size and maturity.
- Josh Konetzni - Senior Vice President, Head of Business Development, VMS BioMarketing
- Marla Hogle - Senior Manager, Patient Support Services, Dexcom
- Nancy Bell - Vice President, Head of US Patient Value & Access, Takeda Oncology
10:15am - 10:45am
Networking and Refreshment Break
Showing 1 of 1 Streams
General Session
10:45am - 11:30am
Best Practices for Vendor Selection and Management – Being Intuitive and Intentional
- Discuss best practices in selecting an effective partner for your hub
- Understand what makes a partnership successful, specifically for a new product or single asset company
- Uncover common partnership gaps and how to catch in advance as you look at the RFP process
- Ensure that your partnership is a solid extension of your own brand to increase it’s longevity
- Jennifer Clark - Senior Director, Patient Services, Menarini Stemline
- Melissa Beatty - Executive Director, Patient Services, Zevra Therapeutics
11:30am - 12:15pm
Automation and Artificial Intelligence – What Does that Mean for your Hub Program?
- Renee Shiota - Senior Director, Trade, Distribution and Patient Services, Mirum Pharmaceuticals, Inc.
12:15pm - 1:30pm
Networking Luncheon
Showing 1 of 1 Streams
General Session
1:30pm - 2:15pm
Addressing Affordability Challenges within a Hub
- Learn more about free drug, bridge and startup programs and how they can be best managed within a hub
- Understand how to integrate patient assistance within your program
- Highlight the main risks and OIG watchouts to compliantly build free drug programs
- Heather Schaefer - Senior Director, Patient Services Enterprise Strategy, Takeda Pharmaceuticals, Inc.
- Andrew Cerri - Group Marketing Manager, Consumer Access, Abbott Diabetes Care
2:15pm - 3:00pm
Enforcement Panel –The Changing Regulatory Landscape of Patient Support Services and Hub Models
- Discuss the use of field-based patient facing roles and their respective watchouts
- Gain valuable insights into the latest enforcement actions and the ramifications of recent cases
- Uncover the top areas of focus for 2024 and beyond
3:00pm - 3:30pm
Networking and Refreshment Break
Showing 1 of 1 Streams
General Session
3:30pm - 4:15pm
Build Sustainable Patient Access Programs While Balancing GTN
- Discuss how industry shifts are affecting manufacturers’ ability to maintain this balance & current issues manufacturers are facing
- Hear how to optimize the value of patient access programs and how vital proper data analysis is to maintaining GTN
- Explore the balance and trade-offs between maintaining effective patient programs while retaining GTN
- Nancy Bell - Vice President, Head of US Patient Value & Access, Takeda Oncology
4:15pm - 5:00pm
Optimizing Pharmaceutical Operations – Key Considerations for Insourced and Hybrid Hub
The choice between insourced hubs, outsourced solutions, or a strategic combination of both is a critical decision for companies seeking operational excellence. This session provides a comprehensive exploration of the key considerations surrounding insourced and hybrid hubs
- Explore advantages and challenges associated with insourced and hybrid models
- Understand strategies for achieving cost optimization through insourcing or hybrid solutions, balancing the benefits of in-house control with potential cost savings
- Examine the adaptability and flexibility afforded by insourced and hybrid hubs
- Discover the role of technology in optimizing insourced and hybrid hubs
- Alex Buell - Lead Director, Sales and Business Development, Cardinal Health™ Sonexus™ Access and Patient Support
- Naveed Masood - Head of US Launch Readiness and Patient Services, Servier
5:00pm - 5:05pm
End of Day 1 and Networking Reception
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats